Kathy Manchulenko

Person

Port Coquitlam, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Interleukin-2 muteins for the expansion of T-regulatory cells
- Patent number 11,976,103
- Issue date May 7, 2024
- Amgen Inc.
- Eric Alan Butz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
TIGIT and CD112R blockade
- Patent number 11,919,953
- Issue date Mar 5, 2024
- Amgen Inc.
- Sue J. Sohn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Interleukin-2 muteins for the expansion of T-regulatory cells
- Patent number 10,851,144
- Issue date Dec 1, 2020
- Amgen Inc.
- Eric Alan Butz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to tumor necrosis factor and uses thereof
- Patent number 8,101,178
- Issue date Jan 24, 2012
- Amgen Fremont Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human monoclonal antibodies to IL-13
- Patent number 7,994,302
- Issue date Aug 9, 2011
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human monoclonal antibodies to IL-13
- Patent number 7,585,500
- Issue date Sep 8, 2009
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Binding proteins specific for human matriptase
- Patent number 7,572,444
- Issue date Aug 11, 2009
- Amgen Fremont Inc.
- Ian Foltz
- G01 - MEASURING TESTING
Information Patent Grant
Antibodies directed to tumor necrosis factor
- Patent number 7,285,269
- Issue date Oct 23, 2007
- Amgen Fremont, Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TIGIT AND CD112R BLOCKADE
- Publication number 20220017616
- Publication date Jan 20, 2022
- Amgen Inc.
- Sue J. SOHN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS
- Publication number 20210139554
- Publication date May 13, 2021
- Amgen Inc.
- Eric Alan BUTZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS
- Publication number 20200024319
- Publication date Jan 23, 2020
- Amgen Inc.
- Eric Alan BUTZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13
- Publication number 20100047253
- Publication date Feb 25, 2010
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF
- Publication number 20080187531
- Publication date Aug 7, 2008
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Binding proteins specific for human matriptase
- Publication number 20060171884
- Publication date Aug 3, 2006
- Ian Foltz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fully human monoclonal antibodies to IL-13
- Publication number 20060140948
- Publication date Jun 29, 2006
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kathy Manchulenko

Person

Patents Grantslast 30 patents

Interleukin-2 muteins for the expansion of T-regulatory cells

TIGIT and CD112R blockade

Interleukin-2 muteins for the expansion of T-regulatory cells

Antibodies directed to tumor necrosis factor and uses thereof

Fully human monoclonal antibodies to IL-13

Fully human monoclonal antibodies to IL-13

Binding proteins specific for human matriptase

Antibodies directed to tumor necrosis factor

Patents Applicationslast 30 patents

TIGIT AND CD112R BLOCKADE

INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS

INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS

FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13

ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF

Binding proteins specific for human matriptase

Fully human monoclonal antibodies to IL-13